BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34993393)

  • 1. Cardiac arrest as first presentation of arrhythmogenic left ventricular cardiomyopathy due to Filamin C mutation: a case report.
    Kandhari N; Khoury S; Behr ER; Miles C
    Eur Heart J Case Rep; 2021 Nov; 5(11):ytab422. PubMed ID: 34993393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing in the management of inherited cardiac disorders: two cases of Filamin-C arrhythmogenic left ventricular cardiomyopathy.
    Abela M; Grech N; Debattista J; Felice T
    Eur Heart J Case Rep; 2023 Nov; 7(11):ytad515. PubMed ID: 37954562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of desmoplakin cardiomyopathy: a mimic of viral myocarditis.
    Rezaei Bookani K; Minga I; Wodskow J; Harris J; Gordon R; Sarswat N; Pursnani A
    Eur Heart J Case Rep; 2022 Aug; 6(8):ytac341. PubMed ID: 36043215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.
    Augusto JB; Eiros R; Nakou E; Moura-Ferreira S; Treibel TA; Captur G; Akhtar MM; Protonotarios A; Gossios TD; Savvatis K; Syrris P; Mohiddin S; Moon JC; Elliott PM; Lopes LR
    Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):326-336. PubMed ID: 31317183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.
    Hall CL; Akhtar MM; Sabater-Molina M; Futema M; Asimaki A; Protonotarios A; Dalageorgou C; Pittman AM; Suarez MP; Aguilera B; Molina P; Zorio E; Hernández JP; Pastor F; Gimeno JR; Syrris P; McKenna WJ
    Int J Cardiol; 2020 May; 307():101-108. PubMed ID: 31627847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: DSP truncation variant p. R1951X leads to arrhythmogenic left ventricular cardiomyopathy.
    Chen V; Knight BP; McNally EM
    Eur Heart J Case Rep; 2022 Mar; 6(3):ytac105. PubMed ID: 35474678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.
    Casella M; Gasperetti A; Sicuso R; Conte E; Catto V; Sommariva E; Bergonti M; Vettor G; Rizzo S; Pompilio G; Andreini D; Saguner AM; Duru F; Natale A; Thiene G; Basso C; Dello Russo A; Tondo C
    Circ Arrhythm Electrophysiol; 2020 Dec; 13(12):e009005. PubMed ID: 33197325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
    Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filamin C (FLNC) truncating mutation in a fatal arrhythmogenic left ventricular cardiomyopathy (ALVC).
    Simonit F; Da Broi U; D'Elia AV; Fabbro D; Mio C; Bussani R; Pinamonti M; Desinan L
    Leg Med (Tokyo); 2024 Mar; 69():102438. PubMed ID: 38547641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arrhythmogenic left ventricular cardiomyopathy].
    Havránek Š; Paleček T; Kuchynka P; Vítková I
    Vnitr Lek; 2016; 62(9):728-735. PubMed ID: 27715074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management.
    Mauriello A; Roma AS; Ascrizzi A; Molinari R; Loffredo FS; D'Andrea A; Russo V
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy.
    Havranek S; Palecek T; Kovarnik T; Vitkova I; Psenicka M; Linhart A; Wichterle D
    BMC Cardiovasc Disord; 2015 Mar; 15():18. PubMed ID: 25887693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death.
    Celeghin R; Cipriani A; Bariani R; Bueno Marinas M; Cason M; Bevilacqua M; De Gaspari M; Rizzo S; Rigato I; Da Pozzo S; Zorzi A; Perazzolo Marra M; Thiene G; Iliceto S; Basso C; Corrado D; Pilichou K; Bauce B
    Heart Rhythm; 2022 Feb; 19(2):235-243. PubMed ID: 34601126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy.
    Graziosi M; Ditaranto R; Rapezzi C; Pasquale F; Lovato L; Leone O; Parisi V; Potena L; Ferrara V; Minnucci M; Caponetti AG; Chiti C; Ferlini A; Gualandi F; Rossi C; Berardini A; Tini G; Bertini M; Ziacchi M; Biffi M; Galie N; Olivotto I; Biagini E
    Open Heart; 2022 Apr; 9(1):. PubMed ID: 35444050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.
    Ortiz-Genga MF; Cuenca S; Dal Ferro M; Zorio E; Salgado-Aranda R; Climent V; Padrón-Barthe L; Duro-Aguado I; Jiménez-Jáimez J; Hidalgo-Olivares VM; García-Campo E; Lanzillo C; Suárez-Mier MP; Yonath H; Marcos-Alonso S; Ochoa JP; Santomé JL; García-Giustiniani D; Rodríguez-Garrido JL; Domínguez F; Merlo M; Palomino J; Peña ML; Trujillo JP; Martín-Vila A; Stolfo D; Molina P; Lara-Pezzi E; Calvo-Iglesias FE; Nof E; Calò L; Barriales-Villa R; Gimeno-Blanes JR; Arad M; García-Pavía P; Monserrat L
    J Am Coll Cardiol; 2016 Dec; 68(22):2440-2451. PubMed ID: 27908349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
    Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
    Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
    Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
    J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of isolated arrhythmogenic left ventricular cardiomyopathy: phenotypes, diagnosis, and treatment.
    Lan Y; Wei L; Pan C; Lin T; Yan Y
    Eur Heart J Case Rep; 2024 Feb; 8(2):ytad581. PubMed ID: 38328600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.